PROGRESS
A Phase 2 Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Effects of Multiple Subcutaneous Injections of Elamipretide on Left Ventricular Function in Subjects with Stable Heart Failure with Reduced Ejection Fraction
- Stage
- klaar
- Medicine
- elamipretide
- Population
- Hartfalen
- Phase
- II
- First Patient In
- 1 September 2016
- Last Patient In
- 18 August 2017
- Last Patient Last Visit
- 30 September 2017
National Lead
prof. dr. A. Voors
Cardioloog
Study Director
dr. D.J.A. Lok
Cardioloog
Board Contact
